Alector
CA - South SF
Biotechnology1 H-1B visas (FY2023)Focus: Alzheimer's Antibody Treatments
Alector is a life sciences company focused on Alzheimer's Antibody Treatments.
Neurology
Open Jobs
2
Pipeline & Clinical Trials
AL003
HealthyClinical Trials (1)
NCT03822208First in Human Study for Safety and Tolerability of AL003.
Phase 1AL002
HealthyClinical Trials (1)
NCT03635047A Phase I Study for Safety and Tolerability of AL002.
Phase 1AL001
HealthyClinical Trials (1)
NCT03636204A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation
Phase 1AL101
HealthyClinical Trials (1)
NCT04111666A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101
Phase 1GSK4527226
Alzheimer's DiseaseClinical Trials (1)
NCT06079190Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
Phase 2Phase 2
Clinical Trials (1)
NCT03987295A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Phase 2AL002
Alzheimer's DiseaseAL002
Alzheimer DiseaseClinical Trials (1)
NCT04592874A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
Phase 2Phase 2
Clinical Trials (1)
NCT05053035A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Phase 2GSK4527226
Alzheimer's DiseaseClinical Trials (1)
NCT07105709Open-label Extension Study in Participants With Early Alzheimer's Disease
Phase 2Phase 3
Clinical Trials (1)
NCT04374136A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
Phase 3Latozinemab
Neurodegenerative DiseasesClinical Trials (1)
NCT06111014Continuation Study for Latozinemab
Phase 3Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 11 clinical trials
H-1B (2023): 1 approval
Open Roles: 2 active jobs
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub